Stomp Wouter, Reijnierse Monique, Kloppenburg Margreet, de Mutsert Renée, Bovée Judith V M G, den Heijer Martin, Bloem Johan L
Department of Radiology, C2-S, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Eur Radiol. 2015 Dec;25(12):3480-7. doi: 10.1007/s00330-015-3764-6. Epub 2015 May 21.
The purpose was to determine prevalence of enchondromas and atypical cartilaginous tumour/chondrosarcoma grade 1 (ACT/CS1) of the knee on MRI in a large cohort study, namely the Netherlands Epidemiology of Obesity (NEO) study.
Participants aged 45 to 65 years were prospectively included, oversampling overweight and obese persons. Within a subgroup of participants, MRI of the right knee was performed and screened for incidental cartilaginous tumours, as defined by their characteristic location and appearance.
Forty-nine cartilaginous tumours were observed in 44 out of 1285 participants (estimated population prevalence 2.8 %, 95 % CI 2.0-4.0 %). Mean largest tumour diameter was 12 mm (range 2-31 mm). Eight participants with a tumour larger than 20 mm or a tumour with aggressive features were referred to rule out low-grade chondrosarcoma. One was lost to follow-up, three had histologically proven ACT/CS1 and four had dynamic contrast MRI findings consistent with benign enchondroma.
Incidental cartilaginous tumours were relatively common on knee MRI and may be regarded as a normal concurrent finding. However, more tumours than expected were ACT/CS1. Because further examination was performed only when suspicion of chondrosarcoma was high, the actual prevalence might be even higher.
• Incidental cartilaginous tumours are relatively common on knee MRI. • Most incidental cartilaginous tumours are small and lack suspicious features. • Small cartilaginous tumours without suspicious findings may be a normal concurrent finding. • Large tumours and/or those with suspicious findings should be further investigated. • Atypical cartilaginous tumour/chondrosarcoma grade 1 was found more often than expected.
在一项大型队列研究即荷兰肥胖流行病学(NEO)研究中,通过磁共振成像(MRI)确定膝关节内生软骨瘤和非典型软骨性肿瘤/1级软骨肉瘤(ACT/CS1)的患病率。
前瞻性纳入45至65岁的参与者,对超重和肥胖者进行过度抽样。在参与者亚组中,对右膝进行MRI检查,并筛查偶然发现的软骨性肿瘤,根据其特征性位置和表现进行定义。
在1285名参与者中的44名中观察到49个软骨性肿瘤(估计总体患病率2.8%,95%置信区间2.0 - 4.0%)。肿瘤最大直径平均为12毫米(范围2 - 31毫米)。8名肿瘤大于20毫米或具有侵袭性特征的参与者被转诊以排除低级别软骨肉瘤。1名失访,3名经组织学证实为ACT/CS1,4名动态对比MRI结果与良性内生软骨瘤一致。
偶然发现的软骨性肿瘤在膝关节MRI上相对常见,可视为正常的并发表现。然而,ACT/CS1的肿瘤比预期的多。由于仅在高度怀疑软骨肉瘤时才进行进一步检查,实际患病率可能更高。
• 偶然发现的软骨性肿瘤在膝关节MRI上相对常见。• 大多数偶然发现的软骨性肿瘤较小且缺乏可疑特征。• 无可疑发现的小软骨性肿瘤可能是正常的并发表现。• 大肿瘤和/或有可疑发现的肿瘤应进一步检查。• 发现非典型软骨性肿瘤/1级软骨肉瘤比预期更频繁。